Research Highlights: Adrenergic receptor pharmacogenetics in heart failure-Reference-Cited by-同舟云学术

Research Highlights: Adrenergic receptor pharmacogenetics in heart failure

Published:2013-10 Issue:13 Volume:14 Page:1545-1549
ISSN:1462-2416
Container-title:Pharmacogenomics
language:en
Short-container-title:Pharmacogenomics

Author:

Lymperopoulos Anastasios¹,Negussie Shmuel²,Walklett Karlee²

Affiliation:

1. Laboratory for the Study of Neurohormonal Control of the Circulation, Department of Pharmaceutical Sciences, Nova Southeastern University College of Pharmacy, HPD (Terry) Building/Room 1338, Fort Lauderdale, FL 33328-2018, USA.

2. Laboratory for the Study of Neurohormonal Control of the Circulation, Department of Pharmaceutical Sciences, Nova Southeastern University College of Pharmacy, HPD (Terry) Building/Room 1338, Fort Lauderdale, FL 33328-2018, USA

Publisher

Future Medicine Ltd

Subject

Pharmacology,Genetics,Molecular Medicine

Link

https://www.futuremedicine.com/doi/pdf/10.2217/pgs.13.137

Reference30 articles.

1. Effects of Beta-Blockers on Implantable Cardioverter Defibrillator Therapy and Survival in the Patients with Ischemic Cardiomyopathy (from the Multicenter Automatic Defibrillator Implantation Trial-II)

2. MetraM, Bristow MR. β-blocker therapy in chronic heart failure. In:Heart Failure: A Companion to Braunwald’s Heart Disease. Mann DL (Ed.). WB Saunders, PA, USA,674–693 (2011).

3. Adrenergic Receptor Polymorphisms and Prevention of Ventricular Arrhythmias With Bucindolol in Patients With Chronic Heart Failure

4. A Trial of the Beta-Blocker Bucindolol in Patients with Advanced Chronic Heart Failure

Cited by 1 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Pharmacogenomics of Bucindolol in Atrial Fibrillation and Heart Failure;Current Heart Failure Reports;2017-10-03